Invest $400,000 in These 4 Dividend Stocks Yielding Over 6% for Retirement Income

Published November 19, 2026, 11:02am ET · 3 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

An elderly woman with white hair and glasses, dressed in a white collared blouse and dark skirt, stands in a modern office. She is holding an open gray folder and looking down at its contents with a focused expression. In the blurred background, there's a large window and a wooden desk with a mug and notebooks.
An elegant senior woman reviews documents, symbolizing the careful consideration often needed for major financial decisions in retirement. Her focus reflects the importance of detailed planning when contemplating significant lifestyle changes and asset management. © YAKOBCHUK VIACHESLAV / Shutterstock.com

Retirees spend decades building a nest egg and then face a different problem: turning it into a paycheck that comes whether markets rise or fall. Part of the gap is covered by Social Security. For many households, the rest has to come from the portfolio, ideally without selling shares into a downturn to pay the bills.

High-yield dividend stocks can do that job. Here’s what a $100,000 stake in these three high-yield names would generate: a $300,000 total investment making more than $18,500 in annual passive income. Each one carries a forward yield above 6% at current prices and passes a coverage check against earnings or distributable cash flow. That coverage matters more as yields rise. At these payout levels, a dividend cut on a $100,000 position would take thousands of dollars a year out of a retiree’s budget.

Enterprise Products Partners

  • Stock #3: Enterprise Products Partners (NYSE:EPD | EPD Price Prediction)
  • Distribution Rate: 6.16%
  • Units for $100,000: 2,748.76
  • Annual Passive Income: ~$6,157

Enterprise runs one of North America’s largest integrated midstream networks, which moves and processes natural gas liquids, crude oil, natural gas and petrochemicals through pipelines, processing plants and marine export terminals. Most of its cash flow comes from fees, and Permian processing intake volumes hit a record 4.6 Bcf/d[1] in Q3 2026.

The high payout comes from the MLP structure, which passes most cash flow through to unitholders. Part of each MLP distribution is typically classified as return of capital, which reduces your cost basis instead of being taxed as current income. Coverage is strong. Q3 operating distributable cash flow of about $2.30 billion[1] covered the $0.56 quarterly distribution 1.9x, leaving $1.1B for growth projects, buybacks and debt reduction.

The payout is up 2.8%[1] year over year. IRA holders should know about UBTI. Under 26 U.S.C. § 512(c)(1)[2], a tax-exempt account counts its share of partnership business income "whether or not distributed." The main risk is execution on $6.3B[1] of growth projects under construction through 2028.

Verizon Communications

  • Stock #2: Verizon Communications (NYSE:VZ)
  • Yield: 6.21%
  • Shares for $100,000: 2,194.43
  • Annual Passive Income: ~$6,210

Verizon is the largest U.S. wireless carrier. It also sells Fios fiber and fixed wireless broadband, plus business communications. In Q3 2026 it added 406,000[3] postpaid phone customers, up from 44,000 a year earlier, and its adjusted EBITDA margin expanded to 40.2%.

The yield is high because this is a mature, capital-heavy business. Revenue grew only 1.4%[3], and 2026 capex will run $16.0-$16.5B. Earnings cover the payout well. Adjusted EPS guidance of $5.04-$5.06[3] covers the $2.83 annual dividend about 1.78 times at the low end, and Q3 free cash flow reached $7.801 billion[4]. The quarterly dividend has gone up every year since at least 2010. The key risk is $166.2B[3] of debt, and interest expense rose 17.2%[4] year over year.

Pfizer

  • Stock #1: Pfizer (NYSE:PFE)
  • Yield: 6.22%
  • Shares for $100,000: 3,615.33
  • Annual Passive Income: ~$6,218

Pfizer sells drugs across oncology (Padcev, Ibrance, Lorbrena), primary care (Eliquis, Prevnar) and specialty care (the Vyndaqel family). Its yield is high because COVID revenue keeps falling. Paxlovid dropped 63%[5] and Comirnaty fell 29% in Q3, and investors also worry about Eliquis generics. The stock is down 28.59% over five years.

The underlying business is holding up. Q3 adjusted EPS of $0.87[5] beat the $0.73 consensus, and the non-COVID portfolio grew 7% operationally. Raised EPS guidance of $2.95-$3.05[5] covers the $1.72 annual dividend about 1.7 times. The risk is history: Pfizer cut its quarterly dividend to $0.16 from $0.32 in 2009. It is also paying down debt and plans no buybacks in 2026.

Income Breakdown for a $300,000 Portfolio

Name Yield or Distribution Rate Annual Dividend Income
Enterprise Products Partners 6.16% $6,157
Verizon 6.21% $6,210
Pfizer 6.22% $6,218
Total 6.20% $18,585

Together, these three positions generate $18,585 in annual passive income on a $300,000 investment, a combined yield of 6.20%. Pfizer contributes $6,218, Verizon adds $6,210, and Enterprise rounds out the group with $6,157.

The payment schedules also fit together. Verizon and Enterprise paid in February, May, August and November, while Pfizer pays in March, June, September and December, so income lands in eight months of the year. For a retiree, that steady cash flow makes budgeting more predictable and reduces the need to sell shares when markets turn.

Contact [email protected] for any questions or corrections.

Lee Jackson

Lee Jackson has covered Wall Street analysts' equity and debt research and equity strategy daily for 24/7 Wall St. since 2012. His broad, diverse career, including a stint as creative services director at an NBC affiliate in Austin, Texas, gives him unique insight into the financial industry.

Lee Jackson's journey in the financial industry spans more than 30 years, including nearly two decades as an institutional equity salesperson at Bear Stearns, Lehman Brothers, and Morgan Stanley. His career spanned pivotal sell-side Wall Street events, from the dot-com rise and bubble to the Long-Term Capital Management debacle, 9/11, and the Great Recession of 2008. This reflects his resilience and adaptability amid market volatility.

Lee Jackson’s practical financial industry experience, gained through a career at some of the biggest banks and brokerage firms, is complemented by a lifetime of writing across various platforms. This unique combination allows him to shed light on the intricacies of Wall Street in a way only someone with deep insider experience and knowledge can. Moreover, his extensive network across Wall Street continues to provide direct access for him and 24/7 Wall St., a privilege few firms enjoy.

Since 2012, Jackson’s work for 24/7 Wall St. has been featured in Barron’s, Yahoo Finance, MarketWatch, Business Insider, TradingView, Real Money, The Street, Seeking Alpha, Benzinga, and other media outlets. He attended the prestigious Cranbrook Schools in Bloomfield Hills, Michigan, and has a degree in broadcasting from the Specs Howard School of Media Arts.

All articles →

Sources

  1. Enterprise Products Partners Form 8-K (Q3 FY2026)U.S. Securities and Exchange Commission
  2. 26 U.S.C. § 512 — Unrelated business taxable incomeOffice of the Law Revision Counsel, U.S. House of Representatives
  3. Verizon Form 8-K (Q3 FY2026)U.S. Securities and Exchange Commission
  4. U.S. Securities and Exchange CommissionU.S. Securities and Exchange Commission
  5. Pfizer Form 8-K (Q3 FY2026)U.S. Securities and Exchange Commission